Clinical trials

Study name: Molecular predictive biomarkers of EGFR inhibitors combined with radiotherapy in head and neck cancer patients.
Study type: Prospective biomarker identification and validation study
Population: Head and neck cancer patients
Protocol number: NS10108
Status: Terminated
Study name: Genomic profiling of locally advanced rectal cancers in prediction of chemotherapy response.
Study type: Prospective biomarker identification and validation study
Population: Rectal cancer patietns
Protocol number: NR9076
Status: Terminated
Study name: A randomized, single-dose, two-way cross-over study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing atorvastatin.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 176/022/04-iqa
Status: Terminated
Study name: Placebo controlled phase II clinical study of antioxidant lycopene on oxidative stress in cystic fibrosis and male infertility patients.
Study type: Placebo controlled phase II study
Population: Cystic fibrosis patients (pediatric and adults), healthy cystic fibrosis heterozygotes, healthy volunteers and infertile men.
Protocol number: 1A8621
Status: Terminated
Study name: A multi-center retrospective study for developing and validating a microRNA based assay for the classification of indeterminate thyroid FNA samples
Study type: Retrospective biomarker identification and validation study
Population: Patients with thyroid diseases, preferrably thyroid cancer
Protocol number: RG-Thyroid-DD-21-28
Status: Terminated